Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.15p
   
  • Change Today:
      0.15p
  • 52 Week High: 6.00
  • 52 Week Low: 1.30
  • Currency: UK Pounds
  • Shares Issued: 4,766.44m
  • Volume: 469,773
  • Market Cap: £197.81m
  • RiskGrade: 268

Latest ShareCast News

Allergy Therapeutics starts dosing peanut allergy vaccine candidate

By Josh White

Date: Monday 27 Mar 2023

(Sharecast News) - Allergy Therapeutics, a UK-based biotechnology company specialising in allergy vaccines, announced the start of the first application of its 'VLP Peanut' vaccine candidate in peanut-allergic patients on Monday.

AGY ShareCast News

Allergy Therapeutics confident in funding as res... 20-Jan-2023 ShareCast
Allergy Therapeutics pauses production at Freema... 04-Oct-2022 ShareCast
Allegy Therapeutics trades 'robustly' in tough y... 15-Jul-2022 ShareCast
Allergy Therapeutics reports positive results fr... 25-Oct-2021 ShareCast
Allergy Therapeutics upbeat on ex-vivo study of ... 03-Aug-2021 ShareCast

AGY Regulatory News

Update on funding 27-Aug-2024 07:00 RNS
Trading update for the year ended 30 June 2024 22-Jul-2024 07:01 RNS
Appointment of Nominated Adviser and Sole Broker 22-Jul-2024 07:00 RNS
Launch of new Company Long Term Incentive Plan 04-Jul-2024 14:22 RNS
Appointment of Non-Executive Director 27-Jun-2024 07:00 RNS

AGY Newspaper Links

Allergy drug firm hit by trials setback 12-Jul-2007 The Independent
Need to Know: Global Business Briefing 25-Mar-2006 Times

AGY Tips & Analysis

FTSE Close: BP and Lloyds lead rally 21-Sep-2010 Daily Mail
Tempus:Allergy Therapeutics 22-Sep-2009 Times
Investment Column:Allergy Therapeutics 22-Sep-2009 The Independent
Market report: Wednesday lastest 14-May-2008 Daily Mail
Market Report: Prudential gains after bid specul... 13-Mar-2008 The Independent

AGY News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 4.15p
Change Today 0.15p
% Change 3.75 %
52 Week High 6.00
52 Week Low 1.30
Volume 469,773
Shares Issued 4,766.44m
Market Cap £197.81m
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.12% below the market average18.12% below the market average18.12% below the market average18.12% below the market average18.12% below the market average
6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average
Price Trend
39.92% above the market average39.92% above the market average39.92% above the market average39.92% above the market average39.92% above the market average
38.78% above the sector average38.78% above the sector average38.78% above the sector average38.78% above the sector average38.78% above the sector average
Income Not Available
Growth
84.33% below the market average84.33% below the market average84.33% below the market average84.33% below the market average84.33% below the market average
87.88% below the sector average87.88% below the sector average87.88% below the sector average87.88% below the sector average87.88% below the sector average

AGY Dividends

No dividends found

Trades for 06-Sep-2024

Time Volume / Share Price
16:35 110,000 @ 4.15p
16:35 35,000 @ 4.15p
16:35 15,000 @ 4.15p
16:35 50,000 @ 4.15p
16:35 10,000 @ 4.15p

AGY Key Personnel

CEO Manuel Llobet

Top of Page